Navigation Links
Symmetry Medical Reports Record Second Quarter 2008 Revenue of $109.8 Million
Date:8/6/2008
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Michigan Cosmetic Surgeon Debunks Top 3 Breast Implant Myths 2Health News:Halloween Events in Sacramento Bring Young and Old Together for a Ghoulish Good Time 2Health News:Halloween Events in Central Valley, Calif. Bring Young and Old Together for a Ghoulish Good Time 2Health News:Halloween Events in Central Valley, Calif. Bring Young and Old Together for a Ghoulish Good Time 3Health News:Mylan Announces Appointment of Joseph F. Haggerty as Senior Vice President and Global General Counsel 2Health News:Healthy planet, places and people at risk 2Health News:ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results 2Health News:ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results 3Health News:ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results 4Health News:ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results 5Health News:ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results 6Health News:ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results 7Health News:ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results 8Health News:ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results 9Health News:ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results 10
Breaking Medicine Technology:RetireSafe Announces Intention to Key Vote Senator Dorgan's Drug Importation Amendment (SA 2793) 2Dynatronics Receives 180-Day NASDAQ Extension 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3AHIP Statement on Passage of Senate Finance Committee Legislation 59409 1AHIP Statement on Passage of Senate Finance Committee Legislation 59409 2Americans United for Lifes Statement on Finance Committee Vote 59407 1New York Senators Chuck Schumer 28D NY 29 and Kirsten Gillibrand 28D NY 29 Join As Co Sponsors of The Lung Cancer Mortality Reduction Act 59405 1New York Senators Chuck Schumer 28D NY 29 and Kirsten Gillibrand 28D NY 29 Join As Co Sponsors of The Lung Cancer Mortality Reduction Act 59405 2New York Senators Chuck Schumer 28D NY 29 and Kirsten Gillibrand 28D NY 29 Join As Co Sponsors of The Lung Cancer Mortality Reduction Act 59405 3